SCHEMBL24933537

SCHEMBL24933537

CCc1nn(-c2cncc([N+](=O)[O-])c2)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP11B2 P19099 7/20 0.40
▸ CYP11B1 P15538 5/20 0.40
▸ KHK P50053 4/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CYP19A1 P11511 3/20 0.38
▸ CYP2C9 P11712 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30163022 0.81 NPC1 (0.42) KMT2AMAPTMEN1CYP11B2CYP11B1
SCHEMBL8372488 0.73 ALDH1A1 (0.66) KHKALDH1A1MAPK1L3MBTL1
SCHEMBL24933448 0.69 SMN1; SMN2 (0.59) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL8541169 0.67 ALDH1A1 (0.43) KMT2AMAPTMEN1RAB9AALDH1A1
SCHEMBL28094372 0.67 POLB (0.44) MAPTLMNAALDH1A1CYP2C9
SCHEMBL13106375 0.66 L3MBTL1 (0.49) KMT2AMAPTMEN1LMNANPC1
SCHEMBL12253490 0.66 NPC1 (0.72) KMT2AMAPTMEN1LMNANPC1
SCHEMBL2549642 0.66 KHK (0.57) KMT2AMAPTMEN1LMNAKHK
SCHEMBL29218170 0.66 FGFR1 (0.53) KMT2AMAPTMEN1PDE4APDE4B
SCHEMBL24934296 0.65 KHK (0.42) KHKPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009475-A1 ROCK2 INHIBITORS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-02-02 — — WO disclosed
Send feedback